LU72273A1 - - Google Patents

Info

Publication number
LU72273A1
LU72273A1 LU72273A LU72273A LU72273A1 LU 72273 A1 LU72273 A1 LU 72273A1 LU 72273 A LU72273 A LU 72273A LU 72273 A LU72273 A LU 72273A LU 72273 A1 LU72273 A1 LU 72273A1
Authority
LU
Luxembourg
Application number
LU72273A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU72273A1 publication Critical patent/LU72273A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum
    • Y10S530/831—Cohn fractions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
LU72273A 1974-04-12 1975-04-11 LU72273A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7413019A FR2267115B1 (en:Method) 1974-04-12 1974-04-12

Publications (1)

Publication Number Publication Date
LU72273A1 true LU72273A1 (en:Method) 1975-08-20

Family

ID=9137624

Family Applications (1)

Application Number Title Priority Date Filing Date
LU72273A LU72273A1 (en:Method) 1974-04-12 1975-04-11

Country Status (15)

Country Link
US (1) US4137222A (en:Method)
JP (1) JPS5529053B2 (en:Method)
AR (1) AR205926A1 (en:Method)
BE (1) BE827852A (en:Method)
BR (1) BR7502230A (en:Method)
CA (1) CA1050885A (en:Method)
DE (1) DE2515666C3 (en:Method)
DK (1) DK139659B (en:Method)
ES (1) ES436525A1 (en:Method)
FR (1) FR2267115B1 (en:Method)
GB (1) GB1469908A (en:Method)
LU (1) LU72273A1 (en:Method)
NL (1) NL7504365A (en:Method)
NO (1) NO143478C (en:Method)
SE (1) SE403705B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK144731C (da) 1976-07-30 1982-10-18 Nordisk Insulinlab Fremgangsmaade til isolering af proteinhormoner stammende fra humant hypofysevaev
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
DE2837168A1 (de) * 1978-08-25 1980-03-06 Blutspendedienst Dt Rote Kreuz Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten immunglobulinloesung
US4439421A (en) * 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
FR2556219B1 (fr) * 1983-12-07 1987-06-26 Merieux Inst Nouveau medicament immunomodulateur, a base de fragments fc d'igg humaines
IL149687A0 (en) * 2002-05-15 2002-11-10 Alexander Condrea Cervical dilator
WO2007032566A1 (ja) * 2005-09-16 2007-03-22 Kenji Yoshida 造血幹細胞増殖剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK79841C (da) * 1952-08-04 1955-09-12 Behringwerke Ag Fremgangsmåde til fremstilling af stabile γ-globulinpræparater.
US2922745A (en) * 1958-01-10 1960-01-26 Ortho Pharma Corp Purification of profibrinolysin
NL286954A (en:Method) * 1962-01-03
US3382227A (en) * 1967-01-30 1968-05-07 Pentex Inc Blood protein fractionation employing 2-ethoxy-6, 9-diamino-acridine-lactate
BE789523A (fr) * 1971-09-29 1973-03-29 Behringwerke Ag B1-glycoproteine specifique de la grossesse et son procede d'isolement
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
US3808124A (en) * 1972-04-14 1974-04-30 American Cyanamid Co Purification of human plasminogen
US3943245A (en) * 1974-02-14 1976-03-09 Armour Pharmaceutical Company Purification of plasminogen

Also Published As

Publication number Publication date
JPS50145517A (en:Method) 1975-11-21
CA1050885A (fr) 1979-03-20
DK139659B (da) 1979-03-26
US4137222A (en) 1979-01-30
DK158075A (en:Method) 1975-10-13
SE7504196L (sv) 1975-10-13
DE2515666A1 (de) 1975-10-23
NO143478B (no) 1980-11-17
BE827852A (fr) 1975-10-13
FR2267115A1 (en:Method) 1975-11-07
NO751295L (en:Method) 1975-10-14
DE2515666C3 (de) 1980-06-26
BR7502230A (pt) 1976-02-10
FR2267115B1 (en:Method) 1977-11-10
DE2515666B2 (de) 1979-10-18
DK139659C (en:Method) 1979-09-17
JPS5529053B2 (en:Method) 1980-07-31
ES436525A1 (es) 1977-01-01
NL7504365A (nl) 1975-10-14
SE403705B (sv) 1978-09-04
NO143478C (no) 1981-02-25
AR205926A1 (es) 1976-06-15
GB1469908A (en) 1977-04-06

Similar Documents

Publication Publication Date Title
FR2261227A1 (en:Method)
AU477223B2 (en:Method)
FR2267115B1 (en:Method)
FR2231092B1 (en:Method)
AR198563A1 (en:Method)
DK137648C (en:Method)
FI190274A7 (en:Method)
CS170715B1 (en:Method)
FR2263783A1 (en:Method)
BG20919A1 (en:Method)
BG20673A1 (en:Method)
AU479758A (en:Method)
CH581893A5 (en:Method)
AU480660A (en:Method)
AU479408A (en:Method)
BG20983A1 (en:Method)
BG20978A1 (en:Method)
BG20941A1 (en:Method)
BG20477A1 (en:Method)
BG20746A1 (en:Method)
BG20742A1 (en:Method)
BG20727A1 (en:Method)
BG20715A1 (en:Method)
BG20708A1 (en:Method)
BG20702A1 (en:Method)